First cell treatment to fight the coronavirus awaits FDA approval for clinical trial

Therapeutics company Celularity is awaiting permission from the FDA to test whether a new cell therapy that boosts immunity could be effective against COVID-19. It has been used for cancer treatments.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.